Real-time monitoring of cisplatin-induced cell death

• Verfasst von: Alborzinia, Hamed [VerfasserIn]
• Verfasst von: Can, Suzan [VerfasserIn]
• Verfasst von: Holenya, Pavlo [VerfasserIn]
• Verfasst von: Scholl, Catharina [VerfasserIn]
• Verfasst von: Lederer, Elke [VerfasserIn]
• Verfasst von: Kitanovic, Igor [VerfasserIn]
• Verfasst von: Wölfl, Stefan [VerfasserIn]
• Titel: Real-time monitoring of cisplatin-induced cell death
• Verf.angabe: Hamed Alborzinia, Suzan Can, Pavlo Holenya, Catharina Scholl, Elke Lederer, Igor Kitanovic, Stefan Wölfl
• E-Jahr: 2011
• Jahr: May 16, 2011
• Umfang: 9 S.
• Fussnoten: Gesehen am 28.02.2022
• Titel Quelle: Enthalten in: PLOS ONE
• Ort Quelle: San Francisco, California, US : PLOS, 2006
• Jahr Quelle: 2011
• Band/Heft Quelle: 6(2011), 5, Artikel-ID e19714, Seite 1-9
• ISSN Quelle: 1932-6203
• DOI: doi:10.1371/journal.pone.0019714
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: Biosensors
• Sach-SW: Breast cancer
• Sach-SW: Cancer treatment
• Sach-SW: Cellular stress responses
• Sach-SW: Gene expression
• Sach-SW: Glycolysis
• Sach-SW: HT29 cells
• Sach-SW: Mitochondria
• K10plus-PPN: 1794044736

Abstract

Since the discovery of cisplatin more than 40 years ago and its clinical introduction in the 1970s an enormous amount of research has gone into elucidating the mechanism of action of cisplatin on tumor cells. With a novel cell biosensor chip system allowing continuous monitoring of respiration, glycolysis, and impedance we followed cisplatin treatment of different cancer cell lines in real-time. Our measurements reveal a first effect on respiration, in all cisplatin treated cell lines, followed with a significant delay by interference with glycolysis in HT-29, HCT-116, HepG2, and MCF-7 cells but not in the cisplatin-resistant cell line MDA-MB-231. Most strikingly, cell death started in all cisplatin-sensitive cell lines within 8 to 11 h of treatment, indicating a clear time frame from exposure, first response to cisplatin lesions, to cell fate decision. The time points of most significant changes were selected for more detailed analysis of cisplatin response in the breast cancer cell line MCF-7. Phosphorylation of selected signal transduction mediators connected with cellular proliferation, as well as changes in gene expression, were analyzed in samples obtained directly from sensor chips at the time points when changes in glycolysis and impedance occurred. Our online cell biosensor measurements reveal for the first time the time scale of metabolic response until onset of cell death under cisplatin treatment, which is in good agreement with models of p53-mediated cell fate decision.